Cargando…

Natural Product-Based Screening for Lead Compounds Targeting SARS CoV-2 M(pro)

Drugs that cure COVID-19 have been marketed; however, this disease continues to ravage the world without becoming extinct, and thus, drug discoveries are still relevant. Since M(pro) has known advantages as a drug target, such as the conserved nature of the active site and the absence of homologous...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jie, Zhou, Xiang, Fu, Lifeng, Xu, Haiyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222270/ https://www.ncbi.nlm.nih.gov/pubmed/37242550 http://dx.doi.org/10.3390/ph16050767

Ejemplares similares

Discovery of Diverse Natural Products as Inhibitors of SARS-CoV-2 M(pro) Protease through Virtual Screening
por: Rubio-Martínez, Jaime, et al.
Publicado: (2021)

Natural Products as Potential Lead Compounds for Drug Discovery Against SARS-CoV-2
por: Ebob, Oyere Tanyi, et al.
Publicado: (2021)

Identification of Aloe-derived natural products as prospective lead scaffolds for SARS-CoV-2 main protease (M(pro)) inhibitors
por: Hicks, Emily G., et al.
Publicado: (2022)

Structure-guided discovery approach identifies potential lead compounds targeting M(pro) of SARS-CoV-2
por: Elmessaoudi-Idrissi, Mohcine, et al.
Publicado: (2020)

Screening of natural compounds from Cyperus rotundus Linn against SARS-CoV-2 main protease (M(pro)): An integrated computational approach
por: Kumar, S. Birendra, et al.
Publicado: (2021)

Microbial Natural Products as Potential Inhibitors of SARS-CoV-2 Main Protease (M(pro))
por: Sayed, Ahmed M., et al.
Publicado: (2020)

Discovery of Polyphenolic Natural Products as SARS-CoV-2 M(pro) Inhibitors for COVID-19
por: Krüger, Nadine, et al.
Publicado: (2023)

Computational investigation of natural compounds as potential main protease (M(pro)) inhibitors for SARS-CoV-2 virus
por: Patel, Chirag N., et al.
Publicado: (2022)

Luminescent Assay for the Screening of SARS‐CoV‐2 M(Pro) Inhibitors
por: Sondag, Daan, et al.
Publicado: (2022)

Virtual and In Vitro Screening of Natural Products Identifies Indole and Benzene Derivatives as Inhibitors of SARS-CoV-2 Main Protease (M(pro))
por: Ang, Dony, et al.
Publicado: (2023)

Putative SARS-CoV-2 M(pro) Inhibitors from an In-House Library of Natural and Nature-Inspired Products: A Virtual Screening and Molecular Docking Study
por: Mazzini, Stefania, et al.
Publicado: (2020)

Structure-based computational screening of 470 natural quercetin derivatives for identification of SARS-CoV-2 M(pro) inhibitor
por: Kakhar Umar, Abd., et al.
Publicado: (2023)

Discovery and evaluation of active compounds from Xuanfei Baidu formula against COVID-19 via SARS-CoV-2 M(pro)
por: Zhang, Min, et al.
Publicado: (2023)

Screening of Natural Products Inhibitors of SARS-CoV-2 Entry
por: González-Maldonado, Pamela, et al.
Publicado: (2022)

Discovery of PL(pro) and M(pro) Inhibitors for SARS-CoV-2
por: Puhl, Ana C., et al.
Publicado: (2023)

Discovery of Natural Lead Compound from Dendrobium sp. against SARS-CoV-2 Infection
por: Jiaranaikulwanitch, Jutamas, et al.
Publicado: (2022)

Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics
por: Pérez-Vargas, Jimena, et al.
Publicado: (2023)

A review of natural products, their effects on SARS-CoV-2 and their utility as lead compounds in the discovery of drugs for the treatment of COVID-19
por: Chapman, Robert L., et al.
Publicado: (2021)

Inhibition of the main protease of SARS-CoV-2 (M(pro)) by repurposing/designing drug-like substances and utilizing nature’s toolbox of bioactive compounds
por: Antonopoulou, Io, et al.
Publicado: (2022)

In-Silico Identification of Natural Compounds from Traditional Medicine as Potential Drug Leads against SARS-CoV-2 Through Virtual Screening
por: Mithilesh, Sai, et al.
Publicado: (2022)

Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M(pro) enzyme through in silico approach
por: Gurung, Arun Bahadur, et al.
Publicado: (2020)

Autochthonous Peruvian Natural Plants as Potential SARS-CoV-2 M(pro) Main Protease Inhibitors
por: Peralta-Moreno, Maria Nuria, et al.
Publicado: (2023)

Spiroindole-containing compounds bearing phosphonate group of potential M(pro)-SARS-CoV-2 inhibitory properties
por: Bekheit, Mohamed S., et al.
Publicado: (2023)

Structure-Based Identification of Natural Products as SARS-CoV-2 M(pro) Antagonist from Echinacea angustifolia Using Computational Approaches
por: Bharadwaj, Shiv, et al.
Publicado: (2021)

Computational Repurposing of Drugs and Natural Products Against SARS-CoV-2 Main Protease (M(pro)) as Potential COVID-19 Therapies
por: Piplani, Sakshi, et al.
Publicado: (2022)

Natural tannins as anti-SARS-CoV-2 compounds
por: Wang, Shao-Chun, et al.
Publicado: (2022)

Virtual screening based on the structure of more than 10(5) compounds against four key proteins of SARS-CoV-2: M(Pro), S(RBD), RdRp, and PL(pro)
por: Nabati, Farzan, et al.
Publicado: (2022)

Screening Malaria-box compounds to identify potential inhibitors against SARS-CoV-2 M(pro), using molecular docking and dynamics simulation studies
por: Ahamad, Shahzaib, et al.
Publicado: (2021)

A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2
por: Zhang, Zhe-Rui, et al.
Publicado: (2020)

Non-covalent SARS-CoV-2 M(pro) inhibitors developed from in silico screen hits
por: Rossetti, Giacomo G., et al.
Publicado: (2022)

High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment
por: Naik, Biswajit, et al.
Publicado: (2020)

Inhibition of SARS-CoV-2 3CL M(pro) by Natural and Synthetic Inhibitors: Potential Implication for Vaccine Production Against COVID-19
por: Ullah, Anwar, et al.
Publicado: (2021)

Molecular modeling study of natural products as potential bioactive compounds against SARS-CoV-2
por: Ribeiro, Rayssa, et al.
Publicado: (2023)

Virtual screening and in vitro validation of natural compound inhibitors against SARS-CoV-2 spike protein
por: Power, Helen, et al.
Publicado: (2022)

Identification of natural compounds targeting SARS-CoV-2 Mpro by virtual screening and molecular dynamics simulations
por: Zhang, Chuanming, et al.
Publicado: (2022)

Prioritisation of Compounds for 3CL(pro) Inhibitor Development on SARS-CoV-2 Variants
por: Jukič, Marko, et al.
Publicado: (2021)

In silico studies of anti-oxidative and hot temperament-based phytochemicals as natural inhibitors of SARS-CoV-2 M(pro)
por: Naderi Beni, Ramin, et al.
Publicado: (2023)

Protocol for production and purification of SARS-CoV-2 3CL(pro)
por: Mazzei, Luca, et al.
Publicado: (2023)

Identification of a Pentasaccharide Lead Compound with High Affinity to the SARS-CoV-2 Spike Protein via In Silico Screening
por: Li, Binjie, et al.
Publicado: (2023)

Discovery of novel SARS-CoV-2 inhibitors targeting the main protease M(pro) by virtual screenings and hit optimization
por: Mercorelli, Beatrice, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4tjp9af9n2smp4muq8f6coe651